Free Trial

JPMorgan Chase & Co. Has $1.25 Million Stake in Aspen Aerogels, Inc. (NYSE:ASPN)

Aspen Aerogels logo with Construction background

JPMorgan Chase & Co. lifted its stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 311.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 105,591 shares of the construction company's stock after purchasing an additional 79,901 shares during the quarter. JPMorgan Chase & Co. owned 0.13% of Aspen Aerogels worth $1,254,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also made changes to their positions in ASPN. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in Aspen Aerogels by 35.7% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 33,043 shares of the construction company's stock valued at $430,000 after acquiring an additional 8,688 shares in the last quarter. EntryPoint Capital LLC raised its position in Aspen Aerogels by 253.9% during the fourth quarter. EntryPoint Capital LLC now owns 28,811 shares of the construction company's stock valued at $342,000 after acquiring an additional 20,670 shares in the last quarter. Vanguard Group Inc. raised its position in Aspen Aerogels by 5.5% during the fourth quarter. Vanguard Group Inc. now owns 4,360,246 shares of the construction company's stock valued at $51,800,000 after acquiring an additional 226,251 shares in the last quarter. Fox Run Management L.L.C. acquired a new position in Aspen Aerogels during the fourth quarter valued at approximately $1,040,000. Finally, KLP Kapitalforvaltning AS acquired a new position in Aspen Aerogels during the fourth quarter valued at approximately $164,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have commented on the company. TD Cowen upgraded Aspen Aerogels to a "strong-buy" rating in a report on Tuesday, March 11th. B. Riley lowered their price target on Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating on the stock in a report on Wednesday, February 19th. StockNews.com upgraded Aspen Aerogels to a "sell" rating in a report on Wednesday, February 19th. Barclays lowered their price target on Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a report on Wednesday, February 19th. Finally, Craig Hallum lowered their price objective on shares of Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a research note on Friday, February 14th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $19.11.

Get Our Latest Stock Analysis on Aspen Aerogels

Aspen Aerogels Price Performance

NYSE:ASPN traded up $0.02 during mid-day trading on Monday, hitting $5.57. The company's stock had a trading volume of 982,376 shares, compared to its average volume of 1,927,042. Aspen Aerogels, Inc. has a fifty-two week low of $4.80 and a fifty-two week high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $457.32 million, a price-to-earnings ratio of 34.81 and a beta of 2.35. The stock has a fifty day moving average of $6.54 and a 200-day moving average of $11.62.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. As a group, equities analysts forecast that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Aspen Aerogels Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Articles

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Should You Invest $1,000 in Aspen Aerogels Right Now?

Before you consider Aspen Aerogels, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.

While Aspen Aerogels currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines